Today’s cyclodextrin:
The great potential of the Aquilon Pharma‘s innovative inhaled solution of budesonide-cyclodextrin is clearly demonstrated on this poster from Didier Cataldo on the main outcomes of the Boreas study on both efficacy and safety.